For providers
Provider resources
Resources designed to educate your practice
Browse the resources below to help you make informed decisions about the Oncodetect™ Molecular Residual Disease (MRD) test and confidently support your patient’s treatment path.
On-demand recording
View our latest presentation
Watch our Industry Expert Theater session from the 2025 Annual Meeting.


All-in-one download
Oncodetect MRD welcome kit
Get everything your practice needs to get started with the Oncodetect MRD test, including ordering instructions, specimen handling instructions, case studies, sample reports, and more.
White paper
Oncodetect MRD test
Uncovering the hidden traces of cancer and empowering more informed cancer decisions.

Forms
Test requisition form
PDF
Complete this form and fax or email it to Exact Sciences to order an Oncodetect MRD test today. You can also quickly complete this form online in our Provider Hub .
New developments
Oncodetect™ Molecular Residual Disease test receives Medicare coverage in colorectal cancer
Coverage includes serial use in patients with stage II, III and resectable stage IV colorectal cancer in the adjuvant and recurrence monitoring settings over a five-year period
Exact Sciences announces expanded clinical validation of the Oncodetect test and molecular residual disease innovation roadmap
The Beta-CORRECT study confirms the clinical utility of the Oncodetect test for recurrence monitoring in stage II, III and resectable stage IV colorectal cancer; a whole-genome Oncodetect test powered by MAESTRO with an ultra-low limit of detection will be introduced in 2026
New evidence validates Oncodetect’s ability to predict recurrence
Results from Alpha-CORRECT, a study with one of the longest MRD surveillance monitoring periods to date, show a positive Oncodetect test result is strongly associated with recurrence in stage III colon cancer patients.
Current MRD clinical studies
By investing in robust research and building a strong network of clinical collaborations, we are committed to making MRD testing an essential tool in cancer care.
General resources
MRD educational brochure
PDF
Learn the fundamentals of Molecular Residual Disease testing and how it can benefit patients with solid tumors.*
Oncodetect limit of detection brochure
PDF
Learn about the sensitivity of the Oncodetect test and data related to limit of detection.
Provider overview video
Learn about the benefits of MRD testing, the Oncodetect testing process, possible results, and more.

Specimen instructions
Tumor tissue specimen instructions
PDF
Pathology specimen requirements and delivery instructions for tumor tissue samples.
Blood specimen instructions
PDF
Oncodetect MRD test phlebotomy and delivery instructions for the clinical lab.
Managed blood draw services
PDF
Information on blood draw services managed by Exact Sciences using phlebotomy partners.
Case studies and sample reports
View sample Oncodetect MRD test reports, along with case studies outlining clinical and pathological scenarios in specific use cases.

Surveillance of a stage III colorectal cancer
A 64-year-old male with no comorbidities was diagnosed with colorectal cancer and underwent surgical resection of the primary tumor.
- Diagnosis: Colorectal cancer (CRC)
- Surgical intervention: Resection of primary tumor
- Post-operative findings: Positive circulating tumor DNA (ctDNA)
Surveillance of a stage II colorectal cancer
PDF
A 62-year-old male underwent resection for high-risk Stage II colorectal cancer. Post-operative molecular residual disease (MRD) was detected using a circulating tumor DNA (ctDNA) assay, indicating an elevated risk of recurrence. View sample report .
Surveillance of a stage IV colorectal cancer
PDF
A 58-year-old female with oligometastatic colorectal cancer underwent neoadjuvant FOLFOX followed by surgical resection of both the primary tumor and the metastatic lesions. View sample report .
Stage III colorectal cancer escalation
PDF
A 60-year-old female with a history of rectal bleeding was diagnosed with colorectal cancer and underwent surgery to remove the tumor. View sample report .

Ordering a test for your patients is fast and easy
Order tests, access results, and receive updates through our Provider Hub.
Have questions?
Call us at +1 866-662-6897 .